Professor of Psychiatry, UCLA
Psychiatry
Dr. Andrew F. Leuchter, MD
Andrew Leuchter is an expert in the field of Psychiatry. He graduated from Baylor College of Medicine. He received awards:"America's Top Doctors", "Top Doctors:LA Area", "Top Doctors:Southern California" and "Super Doctor". Andrew Leuchter is also published. He has 101 publications published. The lastest publication: "Assessing the accuracy of topographic EEG mapping for determining local brain function.' Andrew Leuchter is registered with Medicare and accepts Medicare payments.
Publications
- Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments.
- Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial.
- An Eight-week, Open-trial, Pilot Feasibility Study of Trigeminal Nerve Stimulation in Youth With Attention-deficit/Hyperactivity Disorder.
- Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for Major depression.
- The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder.
- Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study.
- Heart rate variability and treatment outcome in Major depression: A pilot study.
- Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity Disorder: A pilot project.
- Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation).
- Neurophysiologic effects of repeated exposure to antidepressant medication: Are brain functional changes during antidepressant administration influenced by learning pr...
- A genome-wide association study of a sustained pattern of antidepressant response.
- Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints.
- Trigeminal nerve stimulation in major depressive Disorder: acute outcomes in an open pilot study.
- Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in Major depression: a report from the biomarkers for...
- PREDICTIVE SOCIOECONOMIC AND CLINICAL PROFILES OF ANTIDEPRESSANT RESPONSE AND REMISSION.
- Does prior antidepressant treatment of Major depression impact brain function during current treatment?
- Effects of heart disease on depression treatment: results from the COMED study.
- The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine.
- Growth modeling with nonignorable dropout: Alternative analyses of the STAR*D antidepressant trial.
- Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of Major depression.
- Biomarkers to predict antidepressant response.
- Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report.
- Amygdala lateralization at rest and during viewing of neutral faces in major depressive Disorder using low-resolution brain electromagnetic tomography.
- Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive Disorder.
- Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study.
- Use of clinical neurophysiology for the selection of medication in the treatment of major depressive Disorder: the state of the evidence.
- Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals.
- Brain electrical source differences between depressed subjects and healthy controls.
- Changes in brain function during administration of venlafaxine or placebo to normal subjects.
- An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive Disorder.
- Yoga as a Complementary Treatment of Depression: Effects of Traits and Moods on Treatment Outcome.
- Insured and non-insured depressed outpatients: how do they compare?
- The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive Disorder.
- Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for Major depression.
- Does the clinical course of depression determine improvement in symptoms and quality of life?
- Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain.
- Characteristics of insured and noninsured outpatients with depression in STAR(*)D.
- Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study.
- Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo.
- Pretreatment neurophysiologic function and ECT response in depression.
- Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant.
- Longitudinal progression of subclinical structural brain disease in normal aging.
- Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects.
- Early changes in prefrontal activity characterize clinical responders to antidepressants.
- Changes in brain function of depressed subjects during treatment with placebo.
- Schizophrenia and older adults. An overview: directions for research and policy.
- Quantitative electroencephalographic correlates of psychosis in Alzheimer disease.
- Delirium and quantitative EEG.
- Reduced EEG coherence in dementia: state or trait marker?
- Quantitative EEG in patients with AIDS and asymptomatic HIV infection.
- EEG coherence in men with AIDS: association with subcortical metabolic activity.
- Serial quantitative EEG among elderly subjects with delirium.
- Clinical, neuroimaging, and environmental risk differences in monozygotic female twins appearing discordant for dementia of the Alzheimer type.
- Conventional and quantitative EEG in the diagnosis of delirium among the elderly.
- Prevalence and significance of electroencephalographic abnormalities in patients with suspected organic mental syndromes.
- Quantitative EEG in frontotemporal dementia.
- Synaptic dysfunction in Alzheimer''s disease: clinical assessment using quantitative EEG.
- Beta activity in aging and dementia.
- Loss of high-frequency brain electrical response to thiopental administration in Alzheimer's-type dementia.
- Changes in cortical EEG and cholinergic function in response to NGF in rats with nucleus basalis lesions.
- Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography.
- Brain structure and function and the outcomes of treatment for depression.
- EEG power correlates with subcortical metabolic activity in AIDS.
- Effects of cholinergic deafferentation and NGF on brain electrical coherence.
- Altered cerebral energy utilization in late life depression.
- Assessing the accuracy of topographic EEG mapping for determining local brain function.
- EEG abnormalities in nonmedicated panic Disorder.
- Neurophysiologic predictors of treatment response to fluoxetine in Major depression.
- Changes in electrocortical power and coherence in response to the selective cholinergic immunotoxin 192 IgG-saporin.
- Relationship between brain electrical activity and cortical perfusion in normal subjects.
- Clinical neurophysiology using electroencephalography in geriatric psychiatry: neurobiologic implications and clinical utility.
- Executive dysfunction predicts nonresponse to fluoxetine in Major depression.
- Prefrontal changes and treatment response prediction in depression.
- Attenuation of brain high frequency electrocortical response after thiopental in early stages of Alzheimer''s dementia.
- Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals.
- Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers.
- Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study.
- Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia.
- Falling backward in two elderly patients taking bupropion.
- Stable bimodal response to cholinomimetic drugs in Alzheimer's disease. Brain mapping correlates.
- Quantitative measurement of brain electrical activity in delirium.
- Diagnosis and assessment of dementia using functional brain imaging.
- The late-onset psychoses. Clinical and diagnostic features.
- Assessment and treatment of the late-onset psychoses.
- Electroencephalographic spectra and coherence in the diagnosis of Alzheimer's-type and multi-infarct dementia. A pilot study.
- The responsibilities of the state for the prevention and treatment of mental illness among prisoners.
- Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures.
- Electroencephalographic coherence in acquired immune deficiency syndrome.
- Assessment of cerebral perfusion using quantitative EEG cordance.
- Relationships between EEG coherence and neuropsychological tests in dementia.
- Effect of white matter disease on functional connections in the aging brain.
- Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment.
- Midline and right frontal brain function as a physiologic biomarker of remission in Major depression.
- A new paradigm for the prediction of antidepressant treatment response.
- Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive Disorder.
- Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in Major depressive...
- Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study.
- Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in Major depression.
- Painful physical symptoms and treatment outcome in major depressive Disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
- Treatment-refractory posttraumatic stress Disorder (TRPTSD): a review and framework for the future.
Schools
Baylor University
University Of California Los Angeles
UCLA NpiampH
Procedures Preformed
- Psychiatric Evaluation
- Transcranial Magnetic Stimulation (TMS)
Conditions Treated
- Bipolar Disorder
- Major Depressive Disorder
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- Top Doctors:Southern California
- Super Doctor
Education
-
UCLA Neuropsychiatric Hospital -
UCLA Medical Center -
Baylor College of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1518998558 | |
| NPPES Provider LastName | LEUCHTER | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 900950001 | |
| NPPES Provider State | CA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 131.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1518998558 |
| Last Name Of The Provider | LEUCHTER |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
Dr. Diana L. Kapelevich, MD |
|
|
Dr. James E. Spar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Louis C. Simpson Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond J. Friedman, MD |
|
|
Dr. Daniel A. Plotkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina M. Hui, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael R. Irwin, MD |
|
|
Dr. Duane E. McWaine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah E. Hays, MD |
|
|
Dr. David L. Sultzer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geoffrey A. Tucker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Helen Lavretsky, MD
This Doctor is OpenDoctor Recommended.
|